1983
DOI: 10.1002/jnr.490100107
|View full text |Cite
|
Sign up to set email alerts
|

Effects of blinding and pinealectomy on regional brain monoamine concentrations

Abstract: The effects of blinding with or without pineal ablation on brain monoamine levels were studied in male rats. Brain dopamine (DA), norepinephrine (NE), epinephrine (E), and serotonin (5-HT) were measured by radioenzymatic assays. Four weeks following pinealectomy, E levels were significantly enhanced in the frontal cortex. Chronic blinding decreased striatal DA levels and increased striatal 5-HT levels in both sham-operated and pinealectomized (Px) animals. In a second experiment Px animals were sacrificed 1 or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1984
1984
2008
2008

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Melatonin receptors have been demonstrated in the striatum and brainstem reticular formation (Kopp et d., 1980;Vitte rt a]., 1988;Pazo, 1979;Sallanon et nl., 1982). The effect of EMFs on the secretion of melatonin is relevant to the pathogenesis of PSP since melatonin secretion is diminished in patients with the disease (Vaughan et al, 1979) and also because melatonin regulates midbrain and limbic dopaminergic activity (Anton-Tay et al, 1971;Cotzias et al, 1971;Wendel et al, 1974;Bradbury et 01.. 1985;Burton et al, 1991) as well as noradrenergic and serotonerigic activity (Sugden and Morris, 1979;Niles et al, 1983: Aldegunde et al, 1985Miguez et al, 1991). Furthermore, melatonin is now recognized to exert potent neuroprotective effects by inhibiting oxidative stress and neuronal damage (Barlow-Walden et al, 1995;Giusti et al, 1995;Manev et a/., 1996).…”
mentioning
confidence: 99%
“…Melatonin receptors have been demonstrated in the striatum and brainstem reticular formation (Kopp et d., 1980;Vitte rt a]., 1988;Pazo, 1979;Sallanon et nl., 1982). The effect of EMFs on the secretion of melatonin is relevant to the pathogenesis of PSP since melatonin secretion is diminished in patients with the disease (Vaughan et al, 1979) and also because melatonin regulates midbrain and limbic dopaminergic activity (Anton-Tay et al, 1971;Cotzias et al, 1971;Wendel et al, 1974;Bradbury et 01.. 1985;Burton et al, 1991) as well as noradrenergic and serotonerigic activity (Sugden and Morris, 1979;Niles et al, 1983: Aldegunde et al, 1985Miguez et al, 1991). Furthermore, melatonin is now recognized to exert potent neuroprotective effects by inhibiting oxidative stress and neuronal damage (Barlow-Walden et al, 1995;Giusti et al, 1995;Manev et a/., 1996).…”
mentioning
confidence: 99%